Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Jagirdar RM, Bozikas A, Zarogiannis SG, Bartosova M, Schmitt CP, Liakopoulos V.

Int J Mol Sci. 2019 Nov 16;20(22). pii: E5765. doi: 10.3390/ijms20225765. Review.

2.

Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease.

Freise C, Schaefer B, Bartosova M, Bayazit A, Bauer U, Pickardt T, Berger F, Rasmussen LM, Jensen PS, Laube G, Mencarelli F, Arbeiter K, Büscher R, Habbig S, Möller K, Kirchner M, Schaefer F, Schmitt CP, Querfeld U.

Sci Rep. 2019 Jul 16;9(1):10316. doi: 10.1038/s41598-019-46805-5.

3.

Analysis of the Ribonuclease A Superfamily of Antimicrobial Peptides in Patients Undergoing Chronic Peritoneal Dialysis.

Pottanat ND, Brook AC, Bartosova M, Cortado H, Gupta S, Li B, Jackson AR, Vonau M, Cohen S, Ferrara M, Ching CB, Spencer JD, Brauner A, Fraser DJ, Schmitt CP, Eberl M, Ayoob R, Becknell B.

Sci Rep. 2019 May 23;9(1):7753. doi: 10.1038/s41598-019-44219-x.

4.

Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.

Bartosova M, Schaefer B, Vondrak K, Sallay P, Taylan C, Cerkauskiene R, Dzierzega M, Milosevski-Lomic G, Büscher R, Zaloszyc A, Romero P, Lasitschka F, Warady BA, Schaefer F, Ujszaszi A, Schmitt CP.

Front Physiol. 2019 Apr 2;10:356. doi: 10.3389/fphys.2019.00356. eCollection 2019.

5.

Biocompatible Peritoneal Dialysis: The Target Is Still Way Off.

Bartosova M, Schmitt CP.

Front Physiol. 2019 Jan 7;9:1853. doi: 10.3389/fphys.2018.01853. eCollection 2018. Review.

6.

Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.

Schaefer B, Bartosova M, Macher-Goeppinger S, Sallay P, Vörös P, Ranchin B, Vondrak K, Ariceta G, Zaloszyc A, Bayazit AK, Querfeld U, Cerkauskiene R, Testa S, Taylan C, VandeWalle J, Yap Y, Krmar RT, Büscher R, Mühlig AK, Drozdz D, Caliskan S, Lasitschka F, Fathallah-Shaykh S, Verrina E, Klaus G, Arbeiter K, Bhayadia R, Melk A, Romero P, Warady BA, Schaefer F, Ujszaszi A, Schmitt CP.

Kidney Int. 2018 Aug;94(2):419-429. doi: 10.1016/j.kint.2018.02.022.

PMID:
29776755
7.

Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.

Eich G, Bartosova M, Tischer C, Wlodkowski TT, Schaefer B, Pichl S, Kraewer N, Ranchin B, Vondrak K, Liebau MC, Hackert T, Schmitt CP.

PLoS One. 2017 Dec 18;12(12):e0189903. doi: 10.1371/journal.pone.0189903. eCollection 2017.

8.

Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy.

Bartosova M, Schaefer B, Bermejo JL, Tarantino S, Lasitschka F, Macher-Goeppinger S, Sinn P, Warady BA, Zaloszyc A, Parapatics K, Májek P, Bennett KL, Oh J, Aufricht C, Schaefer F, Kratochwill K, Schmitt CP.

J Am Soc Nephrol. 2018 Jan;29(1):268-282. doi: 10.1681/ASN.2017040436. Epub 2017 Oct 18.

9.

Thy-1+/- fibroblast subsets in the human peritoneum.

Kawka E, Witowski J, Bartosova M, Catar R, Rudolf A, Philippe A, Rutkowski R, Schäfer B, Schmitt CP, Dragun D, Jörres A.

Am J Physiol Renal Physiol. 2017 Nov 1;313(5):F1116-F1123. doi: 10.1152/ajprenal.00274.2017. Epub 2017 Jul 19.

10.

miR-21 Promotes Fibrogenesis in Peritoneal Dialysis.

Lopez-Anton M, Lambie M, Lopez-Cabrera M, Schmitt CP, Ruiz-Carpio V, Bartosova M, Schaefer B, Davies S, Stone T, Jenkins R, Taylor PR, Topley N, Bowen T, Fraser D.

Am J Pathol. 2017 Jul;187(7):1537-1550. doi: 10.1016/j.ajpath.2017.03.007. Epub 2017 May 9.

11.

Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.

Burkhardt D, Bartosova M, Schaefer B, Grabe N, Lahrmann B, Nasser H, Freise C, Schneider A, Lingnau A, Degenhardt P, Ranchin B, Sallay P, Cerkauskiene R, Malina M, Ariceta G, Schmitt CP, Querfeld U.

PLoS One. 2016 Nov 15;11(11):e0166050. doi: 10.1371/journal.pone.0166050. eCollection 2016.

12.

Hypoxia increases the heterogeneity of melanoma cell populations and affects the response to vemurafenib.

Pucciarelli D, Lengger N, Takáčová M, Csaderova L, Bartosova M, Breiteneder H, Pastorekova S, Hafner C.

Mol Med Rep. 2016 Apr;13(4):3281-8. doi: 10.3892/mmr.2016.4888. Epub 2016 Feb 10.

PMID:
26936534
13.

Quantitative Histomorphometry of the Healthy Peritoneum.

Schaefer B, Bartosova M, Macher-Goeppinger S, Ujszaszi A, Wallwiener M, Nyarangi-Dix J, Sallay P, Burkhardt D, Querfeld U, Pfeifle V, Lahrmann B, Schwenger V, Wühl E, Holland-Cunz S, Schaefer F, Schmitt CP.

Sci Rep. 2016 Feb 19;6:21344. doi: 10.1038/srep21344.

14.

Increased storage and secretion of phosphatidylcholines by senescent human peritoneal mesothelial cells.

Bartosova M, Rudolf A, Pichl S, Schmidt K, Okun JG, Straub BK, Rutkowski R, Witowski J, Schmitt CP.

Clin Exp Nephrol. 2016 Aug;20(4):544-551. doi: 10.1007/s10157-015-1192-1. Epub 2015 Nov 2.

PMID:
26527208
15.

Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.

Pucciarelli D, Lengger N, Takacova M, Csaderova L, Bartosova M, Breiteneder H, Pastorekova S, Hafner C.

Int J Oncol. 2015 Jul;47(1):81-90. doi: 10.3892/ijo.2015.3010. Epub 2015 May 18.

16.

Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.

Pastorek M, Simko V, Takacova M, Barathova M, Bartosova M, Hunakova L, Sedlakova O, Hudecova S, Krizanova O, Dequiedt F, Pastorekova S, Sedlak J.

Int J Oncol. 2015 Jul;47(1):51-60. doi: 10.3892/ijo.2015.2987. Epub 2015 May 5.

17.

Interference of peritoneal dialysis fluids with cell cycle mechanisms.

Büchel J, Bartosova M, Eich G, Wittenberger T, Klein-Hitpass L, Steppan S, Hackert T, Schaefer F, Passlick-Deetjen J, Schmitt CP.

Perit Dial Int. 2015 May-Jun;35(3):259-74. doi: 10.3747/pdi.2013.00010. Epub 2014 Jul 31.

18.

Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma.

Takacova M, Bartosova M, Skvarkova L, Zatovicova M, Vidlickova I, Csaderova L, Barathova M, Breza J Jr, Bujdak P, Pastorek J, Breza J Sr, Pastorekova S.

Oncol Lett. 2013 Jan;5(1):191-197. Epub 2012 Oct 26.

19.

Methylglyoxal-induced modifications of significant honeybee proteinous components in manuka honey: Possible therapeutic implications.

Majtan J, Klaudiny J, Bohova J, Kohutova L, Dzurova M, Sediva M, Bartosova M, Majtan V.

Fitoterapia. 2012 Jun;83(4):671-7. doi: 10.1016/j.fitote.2012.02.002. Epub 2012 Feb 17.

PMID:
22366273
20.

Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa.

Kivela AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivela J, Parkkila AK, Bartosova M, Mucha V, Novak M, Waheed A, Sly WS, Rajaniemi H, Pastorekova S, Pastorek J.

World J Gastroenterol. 2005 May 7;11(17):2616-25.

Supplemental Content

Loading ...
Support Center